Quantification of eNOS mRNA in the canine cardiac vasculature by competitive PCR

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 2 47-2, 2000, Pages

  Fulton, David ^a   Papapetropoulos, Andreas ^a   Zhang, Xiaoping ^b   Catravas, John D ^c   Hintze, Thomas H ^b   Sessa, William C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Complimentary deoxyribonucleic acid; Endothelium; Microvessels; Nitric oxide; Nitric oxide synthase

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; DOG; ENDOTHELIUM CELL; GENE EXPRESSION; MICROVASCULATURE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLENIC VEIN; VASCULAR ENDOTHELIUM;

EID: 0034099010     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.2.h658     Document Type: Article

References (31)

1. Andries, L. J., D. L. Brutsaert, and S, U. Sys. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ. Res. 82: 195-203, 1998.
2. Cardillo, C., C. M. Kilcoyne, A. A. Quyyumi, R. O. Cannon III, and J. A. Panza. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 97: 851-856, 1998.
3. Drexler, H., D. Hayoz, T. Munzel, H. Just, R. Zelis, and H. R. Brunner. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies. Arzneimittelforschung 44: 455-458, 1994.
4. Feron, O., F. Saldana, J. B. Michel, and T. Michel. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 273: 3125-3128, 1998.
5. Garcia-Cardena, G., R. Fan, V. Shah, R. Sorrentino, G. Cirino, A. Papapetropoulos, and W. C. Sessa. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
6. Garcia-Cardena, G., R. Fan, D. F. Stern, J. Liu, and W. C. Sessa. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271: 27237-27240, 1996.
7. Garcia-Cardena, G., P. Martasek, B. S. Masters, P. M. Skidd, J. Couet, S. Li, M. P. Lisanti, and W. C. Sessa. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 272: 25437-25440, 1997.
8. Gardiner, S. M., A. M. Compton, T. Bennett, R. M. Palmer, and S. Moncada. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15: 486-492, 1990.
9. Garland, C. J., F. Plane, B. K. Kemp, and T. M. Cocks. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci. 16: 23-30, 1995. (published erratum appears in Trends Pharmacol. Sci. 16: 177, 1995)
10. Gebrane-Younes, J., L. Drouet, J. P. Caen, and L. Orcel. Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. Am. J. Pathol. 139: 1471-1484, 1991.
11. Gerritsen, M. E., and M. P. Printz. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Circ. Res. 49: 1152-1163, 1981.
12. Griffith, O. W., and D. J. Stuehr. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57: 707-736, 1995.
13. Kaiser, L., R. C. Spickard, and N. B. Olivier. Heart failure depresses endothelium-dependent responses in canine femoral artery. Am. J. Physiol. Heart Circ. Physiol. 256: H962-H967, 1989.
14. Kichuk, M. R., X. Zhang, M. Oz, R. Michler, G. Kaley, A. Nasjletti, and T. H. Hintze. Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts. Am. J. Cardiol. 80: 137A-142A, 1997.
15. Liu, J., G. Garcia-Cardena, and W. C. Sessa. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35: 13277-13281, 1996.
16. Mayer, B., and B. Hemmens. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22: 477-481, 1997.
17. Michel, T., G. K. Li, and L. Busconi. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90: 6252-6256, 1993.
18. Miller, V. M., and P. M. Vanhoutte. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. Am. J. Physiol. Heart Circ. Physiol. 255: H446-H451, 1988.
19. Nadaud, S., M. Philippe, J. F. Arnal, J. B. Michel, and F. Soubrier. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ. Res. 79: 857-863, 1996.
20. Nagao, T., S. Illiano, and P. M. Vanhoutte. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. Am. J. Physiol. Heart Circ. Physiol. 263: H1090-H1094, 1992.
21. Pieper, G. M., D. A. Mei, P. Langenstroer, and S. T. O'Rourke. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am. J. Physiol. Heart Circ. Physiol. 263: H676-H680, 1992.
22. Saenz de Tejada, I., I. Goldstein, K. Azadzoi, R. J. Krane, and R. A. Cohen. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med. 320: 1025-1030, 1989.
23. Sessa, W. C., G. Garcia-Cardena, J. Liu, A. Keh, J. S. Pollock, J. Bradley, S. Thiru, I. M. Braverman, and K. M. Desai. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J. Biol. Chem. 270: 17641-17644, 1995.
24. Sessa, W. C., K. Pritchard, N. Seyedi, J. Wang, and T. H. Hintze. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74: 349-353, 1994.
25. Shaul, P. W., E. J. Smart, L. J. Robinson, Z. German, I. S. Yuhanna, Y. Ying, R. G. Anderson, and T. Michel. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271: 6518-6522, 1996.
26. Shesely, E. G., N. Maeda, H. S. Kim, K. M. Desai, J. H. Krege, V. E. Laubach, P. A. Sherman, W. C. Sessa, and O. Smithies. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93: 13176-13181, 1996.
27. Smith, C. J., D. Sun, C. Hoegler, B. S. Roth, X. Zhang, G. Zhao, X. B. Xu, Y. Kobari, K. Pritchard, Jr., W. C. Sessa, and T. H. Hintze. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ. Res. 78: 58-64, 1996.
28. Smith, J. M., J. H. Meinkoth, T. Hochstatter, and K. M. Meyers. Differential distribution of von Willebrand factor in canine vascular endothelium. Am. J. Vet. Res. 57: 750-755, 1996.
29. Tsai, S. J., and M. C. Wiltbank. Quantification of mRNA using competitive RT-PCR with standard-curve methodology. Biotechniques 21: 862-866, 1996.
30. Wang, J., N. Seyedi, X. B. Xu, M. S. Wolin, and T. H. Hintze. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am. J. Physiol. Heart Circ. Physiol. 266: H670-H680, 1994.
31. Zhang, X., Y. W. Xie, A. Nasjletti, X. Xu, M. S. Wolin, and T. H. Hintze. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 95: 176-182, 1997.